The pathway by the Canadian Cardiovascular Society outlines goals for patients after an acute coronary syndrome—and the responsibilities of each healthcare provider.
Joint U.S.–Taiwan study evaluates the risk of ventricular arrhythmia or sudden death in patients on an antipsychotic, then prescribed a selective serotonin reuptake inhibitor.